As TIM-3 is expressed on multiple immune cell types, changes in mRNA levels could reflect shifts in cell population composition (as would be expected in relation to immune disease pathogenic mechanisms) rather than altered TIM-3 expression in individual cells, such as an increased proportion of cells expressing lower transcript levels. This evidence concerns the gene HAVCR2 and immune system disorder.